Back to Search
KARL BOEHM, DO
DO
Emergency Medicine Physician
NPI: 1952756546Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
12192A(WY)TL5750(WY)TP129(KY)R5702(TX)
Research & Publications (20)
Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy.
PMID 19633050·Ann Oncol·2010
3-trial
Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer.
PMID 19224848·J Clin Oncol·2009
3-trial
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
Green tea (Camellia sinensis) for the prevention of cancer.
PMID 19588362·Cochrane Database Syst Rev·2009
1-meta
Thermodynamic analysis of denaturant-induced unfolding of HodC69S protein supports a three-state mechanism.
PMID 18549245·Biochemistry·2008
8-other
Favorable survival observed after carboplatin, paclitaxel, and concurrent accelerated hyperfractionated radiotherapy for treatment of locally advanced head and neck carcinoma.
PMID 18473121·Invest New Drugs·2008
3-trial
Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network.
PMID 18813198·Cancer Control·2008
6-review
Results of a phase II trial of cetuximab plus capecitabine/irinotecan as first-line therapy for patients with advanced and/or metastatic colorectal cancer.
PMID 19036692·Clin Colorectal Cancer·2008
3-trial
Phase II trial of sunitinib for the therapy of progressive metastatic castration-refractory prostate cancer after previous docetaxel chemotherapy.
PMID 18824440·Clin Genitourin Cancer·2008
3-trial
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
PMID 17897959·Ann Oncol·2008
3-trial
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancer.
PMID 18621615·Clin Breast Cancer·2008
3-trial
Application of pressure-modulated differential scanning calorimetry to the determination of relaxation kinetics of multilamellar lipid vesicles.
PMID 16831505·Biophys Chem·2007
8-other
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapy.
PMID 18272030·Clin Genitourin Cancer·2007
3-trial
Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions.
PMID 17594189·Expert Opin Investig Drugs·2007
6-review
Stability, unfolding, and structural changes of cofactor-free 1H-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase.
PMID 17371045·Biochemistry·2007
8-other
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
PMID 17135639·J Clin Oncol·2006
3-trial
Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer.
PMID 17026805·Clin Genitourin Cancer·2006
3-trial
A phase II study of weekly paclitaxel/estramustine/carboplatin in hormone-refractory prostate cancer.
PMID 17026801·Clin Genitourin Cancer·2006
3-trial
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
PMID 16926223·J Clin Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1233 E 2ND ST
CASPER, WY 82601 - Phone
- (307) 577-7201
Quick Facts
- NPI
- 1952756546
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile